Tag: Astrazeneca

Posted on

Abbott to Develop CDx for AstraZeneca Asthma Drug – GenomeWeb

Abbott to Develop CDx for AstraZeneca Asthma Drug
GenomeWeb
NEW YORK (GenomeWeb) – AstraZeneca has inked an agreement with Abbott to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the investigational therapy, tralokinumab, developed by …
AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma PatientsStreetInsider.com
Diagnostic Tests for Biologic Asthma Therapy Under DevelopmentPharmacy Times
Drugmaker dives into personalized medicine for asthma, heart diseaseHealthcare Packaging
Cambridge News –London South East
all 8 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients – StreetInsider.com

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients
StreetInsider.com
AstraZeneca (NYSE: AZN) announced that it has entered an agreement with Abbott (NYSE: ABT), a global healthcare company, to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the …
AstraZeneca Enters Companion Diagnostic Test Deal With AbbottLondon South East

all 3 news articles »

View full post on asthma – Google News

Posted on

Amgen, AstraZeneca prep a brodalumab pitch–after scuttling asthma program – FierceBiotech

Amgen, AstraZeneca prep a brodalumab pitch–after scuttling asthma program
FierceBiotech
Amgen and its partner AstraZeneca are winding up to deliver U.S. and European applications for their big blockbuster hopeful brodalumab for plaque psoriasis by mid-year. But their last shot to push ahead with the drug in asthma ran into defeat, with …

View full post on asthma – Google News

Posted on

Practice Fusion And AstraZeneca Partner for PHM Initiative For Asthma, COPD – Lung Disease News


Lung Disease News

Practice Fusion And AstraZeneca Partner for PHM Initiative For Asthma, COPD
Lung Disease News
The program provides data-driven insights that can assist members in their commitment to improving care for those suffering with chronic obstructive pulmonary disease (COPD) or asthma. The program is sponsored by AstraZeneca and being advanced by …
AstraZeneca and EHR firm to use drug alert systemPMLiVE

all 3 news articles »

View full post on asthma – Google News

Posted on

Practice Fusion, AstraZeneca Partner on PHM Initiative for Asthma & COPD – HIT Consultant

Practice Fusion, AstraZeneca Partner on PHM Initiative for Asthma & COPD
HIT Consultant
The program, developed by Practice Fusion and sponsored by AstraZeneca, identifies patients whose current asthma or COPD care does not meet evidence-based clinical guidelines, and then alerts physicians at the point of care via patient charts within …
Practice Fusion partners with AstraZenecaMedical Marketing and Media
Aseptika secures US patent for its innovative respiratory infection testCambridge News

all 3 news articles »

View full post on asthma – Google News

Posted on

Practice Fusion and AstraZeneca Partner on Population Health Management … – PR Newswire (press release)

Practice Fusion and AstraZeneca Partner on Population Health Management …
PR Newswire (press release)
The program, developed by Practice Fusion and sponsored by AstraZeneca, identifies patients whose current asthma or COPD care does not meet evidence-based clinical guidelines, and then alerts physicians at the point of care via patient charts within …
Aseptika secures US patent for its innovative respiratory infection testCambridge News

all 2 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca Gets Positive Results for Asthma Drug – Drug Discovery & Development

AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development
AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and …
AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbusterFierceBiotech
AstraZeneca share price: Novel drug shows positive results for severe asthmaiNVEZZ
AstraZeneca's benralizumab succeeds in severe asthmaPharmaTimes

all 5 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster – FierceBiotech

AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster
FierceBiotech
Benralizumab–an IL-5 antibody–reduced the rate of asthma exacerbations, hitting the primary endpoint in the trial, says AstraZeneca ($AZN). But the study flagged weak results for the low end of the doses used in the trial, with the top dose doing …
AstraZeneca share price: Novel drug shows positive results for severe asthmaiNVEZZ
AstraZeneca's benralizumab succeeds in severe asthmaPharmaTimes

all 4 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca starts Phase III program for asthma drug tralokinumab – Pharmaceutical Business Review

AstraZeneca starts Phase III program for asthma drug tralokinumab
Pharmaceutical Business Review
AstraZeneca has started the Phase III program for an investigational human monoclonal antibody tralokinumab, a potential treatment for patients with severe, inadequately controlled asthma, developed by the company's global biologics research and …

View full post on asthma – Google News